eSTI2 has developed the capacity to undertake diagnostic evaluations through all stages of the development pipeline, from proof of concept to CE marking. There is a growing network of specialist sexual health/ GUM clinics and agreements in place with the UK National Research Ethics (NRES) review board to assist both Small and Medium sized Enterprises (SME) and large diagnostic companies with high quality evaluations of point of care tests for STIs.

eSTI2 collaborates with companies to create appropriate protocols to move prototype diagnostic devices step-wise through evaluations from preclinical testing with synthetic samples to diagnostic evaluation with clinical samples for regulatory approval (CE marking).


Partners that eSTI2 are currently working with include:-


  TwistDx Limited
  Atlas Genetics
>   Cepheid